Here are the reasons for top movers today
Monday, Jan 8, 2024 5:40 pm ET
AMAM --
DADA --
DTC --
HARP --
ARDX stock gained on Jan 08, 2024 as the company provided positive updates on the commercial performance and outlook of its drug IBSRELA. In a presentation and webcast, Ardelyx estimated IBSRELA annual net sales to reach over $1 billion and reiterated FY2024 guidance of $140-150 million.